胖子2015年10月22在Englewood Hospital肠癌切除手术前的各种血检结果和数据

1. Oct 14, 2015. 12 Lead ECG

Ventricular Rate 95 BPM
Atrial Rate 95 BPM
P-R Interval 166 ms
QRS Duration 78 ms
Q-T Interval 372 ms
QTC Calculation(Bezet) 467 ms
P Axis 92 degrees
R Axis -16 degrees
T Axis 30 degrees
Diagnois Line Sinus rhythm with occasional Premature ventricular complexes
Diagnois Line Inferior myocardial infarction , age undetermined
Diagnois Line ST & T wave abnormality, consider lateral ischemia
Diagnois Line Abnormal ECG
Diagnois Line No previous ECGs available
http://MUSEPROD/musescripts/museweb.dll?RetrieveTestByDateTime?PatientID=010153577&Date=14-10-2015&Time=13%3a24%3a38%3a255&TestType=ECG&Site=1&OutputType=PDF&Ext=PDF

2. Oct 14, 2015. CA19-9. 20099W

Analyte	Value	Status
CA 19-9	27 U/ML	Final
CA 19-9		Final
Notes: Reference range: SEE COMMENT This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. CA 19-9 levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. Test Performed at: Quest Diagnostics One Malcolm Avenue Teterboro, NJ 07608 Lawrence Tsao, M.D.

3. Oct 14, 2015 CEA

Analyte	Value	Flag	Reference	Status
CEA	4.2 NG/ML	H		Final

4. Oct 14, 2015. TOTAL LDH

TOTAL LDH

Analyte	Value	Flag	Reference	Status
TOTAL LDH	590 U/L		313-618	Final

5. Oct 14, 2015. HBA1C W EAG

HBA1C W EAG

Analyte	Value	Flag	Status
EST. AVG. GLUCOSE	169 MG/DL		Final
HEMOGLOBIN A1C	7.5 %	H	Final
HEMOGLOBIN A1C			Final
Notes: ADA RECOMMENDATIONS: DIAGNOSIS: 5.7-6.4% PREDIABETIC =OR>6.5% TYPE 2 DIABETIC DIABETIC CONTROL: GLYCOHEMOGLOBIN ASSAYS SHOULD BE PERFORMED AT LEAST TWICE YEARLY FOR THE PATIENT WHO HAS STABLE GLYCEMIC CONTROL.=5%>

6. Oct 14, 2015 FERRITIN

FERRITIN

Analyte	Value	Flag	Reference	Status
FERRITIN	354.0 NG/ML		17.9-464	Final

7. Oct 14, 2015 MISYS EHMC

CHEM SCREEN

Analyte	Value	Flag	Reference	Status
ALBUMIN	4.0 G/DL		3.5-5.0	Final
ALK PHOS	87 U/L		38-126	Final
ALT	28 U/L		21-72	Final
ANION GAP W/ K	15 MMOL/L		9-18	Final
AST	22 U/L		17-59	Final
BILIRUBIN,TOTAL	0.6 MG/DL		0.2-1.3	Final
BUN	25 MG/DL	H	9-20	Final
CALCIUM	9.0 MG/DL		8.4-10.2	Final
CHLORIDE	102 MMOL/L		98-107	Final
CO2	25 MMOL/L		22-30	Final
CREATININE	1.4 MG/DL	H	0.7-1.3	Final
GFR, EST. BY MDRD	52.0 ML/MIN/1.73M SQ	L	>60	Final
GLUCOSE	230 MG/DL	H	74-106	Final
GLUCOSE				Final
Notes: (AMERICAN DIABETES ASSOCIATION RECOMMENDATION) FASTING GLUCOSE 100-125 PREDIABETIC 126 OR HIGHER DIABETIC
POTASSIUM	4.4 MMOL/L		3.5-5.1	Final
SODIUM	138 MMOL/L		137-145	Final
TOTAL PROTEIN	6.9 G/DL		6.3-8.2	Final
GFR COMMENT				Final
Notes: IF PATIENT IS OF AFRICAN DESCENT, MULTIPLY ESTIMATED GFR BY 1.21.

8.Oct 14, 2015 TYPE & SCREEN (XM CONVERTIBLE)

TYPE & SCREEN (XM CONVERTIBLE)

Analyte	Value	Status
TYPE & SCREEN (XM CONVERTIBLE)		Final
Notes: CROSSMATCH EXPIRATION:10/22/2015
TYPE & SCREEN (XM CONVERTIBLE)		Final
Notes: ABO/RH(D):O NEGATIVE ANTIBODY SCREEN:NEGATIVE
TYPE & SCREEN (XM CONVERTIBLE)		Final
Notes: BLOOD COMPONENT TYPE:RED CELLS
TYPE & SCREEN (XM CONVERTIBLE)	UNITS ORDERED:0	Final

9. Oct 14, 2015 IRON PANEL

PANEL

Analyte	Value	Flag	Reference	Status
TSI	18 %		15-50	Final
IRON	46 UG/DL	L	49-181	Final
TIBC	261 UG/DL

10. Oct 14, 2015 PTPTT

PTPTT

Analyte	Value	Reference	Status
INR	1.0	0.9-1.1	Final
INR			Final
Notes: LEVEL OF THERAPY 2.0-3.0 DEEP VEIN THROMBOSIS, PULMONARY EMBOLISM, ATRIAL FIBRILLATION, PREVENTION OF SYST.EMBOLI IN VALVULAR HEART DISEASE, ACUTE MYOCARDIAL INFARCTION. 2.5-3.5 PREVENTION OF SYSTEMIC EMBOLISM WITH MECHANICAL HEART VALVES. 3.0-4.0 ANTIPHOSPHOLIPID ANTIBODY SYNDROME. 3.0-4.5 PREVENTION OF SYSTEMIC EMBOLISM IN HIGH RISK PATIENTS WITH MECHANICAL MITRAL OR AORTIC VALVES, RECURRENT SYSTEMIC EMBOLISM.
PT	13.1 SECS	11.8-14.8	Final
PT			Final
Notes: PLEASE NOTE NEW REFERENCE RANGE
PTT	33 SECS	24-38	Final

Provider Comments: This result has been automatically released to your health record at the direction of your provider. Your provider may not have yet reviewed this result.

11. Oct 14, 2015 DIFFERENTIAL

DIFFERENTIAL

Analyte	Value	Flag	Reference	Status
BASO	0.2 %		0.0-1.5	Final
BASO ABSOLUTE	0.0 K/UL		0.0-0.2	Final
DIFF TYPE				Final
Notes: AUTOMATED DIFF
EO	0.9 %		0.1-4.5	Final
EO ABSOLUTE	0.1 K/UL		0.0-0.5	Final
LYMPH	8.3 %	L	19.4-45.4	Final
LYMPH ABSOLUTE	0.7 K/UL	L	1.2-3.4	Final
MONO	5.9 %		1.6-11.3	Final
MONO ABSOLUTE	0.5 K/UL		0.0-0.8	Final
NEUTRO	84.7 %	H	44.1-69.7	Final
NEUTRO ABSOLUTE	7.3 K/UL		1.8-7.7	Final

Provider Comments: This result has been automatically released to your health record at the direction of your provider. Your provider may not have yet reviewed this result.

12. Oct 14, 2015 CBC WITH DIFF BATTERY

CBC WITH DIFF BATTERY

Analyte	Value	Flag	Reference	Status
HCT	32.8 %	L	35.0-47.0	Final
HGB	11.4 G/DL	L	13.5-18.0	Final
MCH	31.1 PG		26.0-34.0	Final
MCHC	34.8 G/DL		32.0-36.0	Final
MCV	89.3 FL		81.8-97.8	Final
PLT	213 K/UL		140.0-400.0	Final
RBC	3.67 M/UL	L	4.00-5.70	Final
RDW	13.7 %		10.0-15.2	Final
WBC	8.6 K/UL		4.5-11.0	Final

Provider Comments: This result has been automatically released to your health record at the direction of your provider. Your provider may not have yet reviewed this result